Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines

被引:64
作者
Durbin, AP
Karron, RA
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Dept Int Hlth, Baltimore, MD 21205 USA
[2] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA
关键词
D O I
10.1086/379775
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Respiratory syncytial virus ( RSV) and human parainfluenza viruses ( hPIVs) are leading causes of viral lower respiratory tract illness in children and in high- risk adult populations. Despite decades of research, licensed vaccines for RSV and hPIVs do not exist. Recently, however, genetically engineered live attenuated RSV and hPIV candidate vaccines have been generated, several of which are already being evaluated in clinical trials. Recombinant technology allows candidate vaccines to be " fine-tuned" in response to clinical data, which should hasten the development of vaccines against these important respiratory pathogens.
引用
收藏
页码:1668 / 1677
页数:10
相关论文
共 119 条
[81]   Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment [J].
Plotnicky-Gilquin, H ;
Huss, T ;
Aubry, JP ;
Haeuw, JF ;
Beck, A ;
Bonnefoy, JY ;
Nguyen, TN ;
Power, UF .
VIROLOGY, 1999, 258 (01) :128-140
[82]   Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein [J].
Plotnicky-Gilquin, H ;
Goetsch, L ;
Huss, T ;
Champion, T ;
Beck, A ;
Haeuw, JF ;
Nguyen, TN ;
Bonnefoy, JY ;
Corvaïa, N ;
Power, UF .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5637-5645
[83]   A role for immune complexes in enhanced respiratory syncytial virus disease [J].
Polack, FP ;
Teng, MN ;
Collins, PL ;
Prince, GA ;
Exner, M ;
Regele, H ;
Lirman, DD ;
Rabold, R ;
Hoffman, SJ ;
Karp, CL ;
Kleeberger, SR ;
Wills-Karp, M ;
Karron, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :859-865
[84]   Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment [J].
Power, UF ;
PlotnickyGilquin, H ;
Huss, T ;
Robert, A ;
Trudel, M ;
Stahl, S ;
Uhlen, M ;
Nguyen, TN ;
Binz, H .
VIROLOGY, 1997, 230 (02) :155-166
[85]   Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein [J].
Power, UF ;
Plotnicky-Gilquin, H ;
Goetsch, L ;
Champion, T ;
Beck, A ;
Haeuw, JF ;
Nguyen, TN ;
Bonnefoy, JY ;
Corvaïa, N .
VACCINE, 2001, 19 (17-19) :2345-2351
[86]   Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults [J].
Power, UF ;
Nguyen, TN ;
Rietveld, E ;
de Swart, RL ;
Groen, J ;
Osterhaus, ADME ;
de Groot, R ;
Corvaia, N ;
Beck, A ;
Bouveret-le-Cam, N ;
Bonnefoy, JY .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11) :1456-1460
[87]   Epidemiology and clinical impact of parainfluenza virus infections in otherwise healthy infants and young children <5 years old [J].
Reed, G ;
Jewett, PH ;
Thompson, J ;
Tollefson, S ;
Wright, PF .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :807-813
[88]  
SALES V, 2001, 4 INT S RESP VIR INF, P12
[89]   Bovine parainfluenza virus type 3 (BPIV3) fusion and hemagglutinin-neuraminidase glycoproteins make an important contribution to the restricted replication of BPIV3 in primates [J].
Schmidt, AC ;
McAuliffe, JM ;
Huang, A ;
Surman, SR ;
Bailly, JE ;
Elkins, WR ;
Collins, PL ;
Murphy, BR ;
Skiadopoulos, MH .
JOURNAL OF VIROLOGY, 2000, 74 (19) :8922-8929
[90]   Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3 [J].
Schmidt, AC ;
McAuliffe, JM ;
Murphy, BR ;
Collins, PL .
JOURNAL OF VIROLOGY, 2001, 75 (10) :4594-4603